Globus Medical Financial Diagnostics

GMED -- USA Stock  

USD 54.94  0.15  0.27%

The modest gains experienced by current holders of Globus Medical may raise some interest from investors. The Stock closed today at a share price of 54.94 on 1 in trading volume. The company executives have been quite successful with maneuvering the stock at opportune times to take advantage of all market conditions in October. The stock standard deviation of daily returns for 30 days (very short) investing horizon is currently 1.4234. The below-average Stock volatility is a good sign for a longer term investment options and for buy-and-hold investors. This diagnostics interface makes it easy to digest most current publicly released information about Globus Medical as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Globus Medical price relationship with some important fundamental indicators such as market cap and management efficiency. Please also check Risk vs Return Analysis.

Globus Medical Note

About 92.0% of the company shares are owned by institutional investors. The book value of Globus Medical was currently reported as 5.4. The company has Price/Earnings To Growth (PEG) ratio of 2.83. Globus Medical had not issued any dividends in recent years. Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. Globus Medical, Inc. was founded in 2003 and is headquartered in Audubon, Pennsylvania. Globus Medical operates under Medical Appliances Equipment classification in USA and is traded on BATS Exchange. It employs 1800 people. To learn more about Globus Medical call David Paul at 610-930-1800 or check out

Globus Medical Alerts

Globus Medical Upcoming and Recent Events

Upcoming Quarterly Earning ReportFebruary 20, 2020
Next Earnings ReportMay 7, 2020
Next Fiscal Quarter EndDecember 31, 2019
Next Fiscal Year EndFebruary 20, 2020
Last Quarter Report DateSeptember 30, 2019
Last Earning Anouncement DateDecember 31, 2018

Globus Medical Earning Estimates

EPSEstimate Date
Quarterly Estimate0.52February 20, 2020
Globus Medical normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Globus Medical SEC Filings

Financial Statements and Exhibits. Results of Operations and Financial Condition
Financial Statements and Exhibits. Results of Operations and Financial Condition
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Submission of Matters to a Vote of Security Holders
Financial Statements and Exhibits. Results of Operations and Financial Condition
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Financial Statements and Exhibits. Results of Operations and Financial Condition
Unclassified Corporate Event

Globus Medical Thematic Classifications

Obamacare Repeal IdeaObamacare Repeal
Large healthcare related equities associated with Obamacare
Baby Boomer Prospects IdeaBaby Boomer Prospects
Mega stocks, funds and ETFs that tend to appeal to people considering retirement from the work force
Medical Equipment IdeaMedical Equipment
USA Equities from Medical Equipment industry as classified by Fama & French
Obamacare IdeaObamacare
Companies that count on Obamacare to take off

Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 5.14 B.


The company has Profit Margin (PM) of 0.23 % which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 29.12 % which suggests for every 100 dollars of sales it generated a net operating income of 0.29.

Stock Holders for Globus Medical

At Risk
Aberdeen U S Multi Cap Equity(0.0464) (1.30) 
Nasdaq US 600 Mid Cap Growth Ne(0.07) (1.84) 
Nasdaq US 600 Mid Cap Growth In(0.06) (1.90) 
Nasdaq AlphaDEX Mid Cap Core In(0.10) (0.47) 
Nasdaq US Multi Cap Growth Net(0.08) (2.17) 
Nasdaq AlphaDEX Multi Cap Growt(0.06) (2.13) 
Nasdaq DM Ex Korea Small Cap AU(0.06) (1.11) 
Nasdaq DM Ex Korea JPY 0.0042 (0.95) 
Nasdaq DM Ex Korea CAD NTR(0.24) (0.17) 
Nasdaq US Multi Cap Growth Tota(0.0444) (2.17) 
Nasdaq DM Ex Korea Small Cap EU(0.0477) (1.22) 
Nasdaq US 700 Small Cap Total R(0.0143) (2.38) 
Nasdaq US Small Cap Growth Inde(0.11) (3.30) 
Nasdaq DM Ex Korea EUR NTR 0.0147 (0.26) 
Nasdaq Yewno Global Disruptive(0.0465) (1.84) 
Nasdaq US 600 Mid Cap Index(0.15) (0.31) 
Nasdaq Yewno Global Disruptive(0.06) (1.64) 
Nasdaq Yewno Global Disruptive(0.0334) (1.76) 
Nasdaq US Contrarian Value Net(0.0026) (1.37) 
NYSE(0.0091) (2.14) 

Technical Drivers

As of 16 of November Globus Medical retains Downside Deviation of 1.4, Market Risk Adjusted Performance of 0.2031 and Risk Adjusted Performance of 0.1034. Globus Medical technical analysis makes it possible for you to employ historical prices and volume momentum with intention to determine a pattern that calculates the direction of the corporation future prices. In other words you can use this information to find out if the corporation will indeed mirror its model of historical price patterns or the prices will eventually revert. We found nineteen technical drivers for Globus Medical which can be compared to its competitors. Please check out Globus Medical Value At Risk, and the relationship between Jensen Alpha and Semi Variance to decide if Globus Medical is priced fairly providing market reflects its last-minute price of 54.94 per share. Given that Globus Medical has Jensen Alpha of 0.0597, we strongly advise you confirm Globus Medical regular market performance to make sure the company can sustain itself at future point.

Globus Medical Price Movement Analysis

The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Weighted Moving Average calculates a weight for each value in Globus Medical price series with the more recent values given greater weights. View also all equity analysis or get more info about weighted moving average overlap studies indicator.

Globus Medical Insider Trading Activities

Globus Medical Predictive Indicators

Globus Medical Forecast Models


Globus Medical Analyst Recommendations

Target PriceAdvice# of Analysts
Globus Medical current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Globus Medical Analyst Advice  

Vital Value Indicators

Globus Medical Basic Pricing Drivers

Quick Ratio4.58
Fifty Two Week Low38.01
Revenue Growth15.90%
Shares Short Prior Month2.23M
Average Daily Volume Last 10 Day704.08k
Average Daily Volume In Three Month462.12k
Earnings Growth8.60%
Shares Percent Shares Out1.62%
Gross Margins76.98%
Earnings Quarterly Growth8.80%
Short Percent Of Float2.44%
Forward Price Earnings28.76
Float Shares75.87M
Fifty Two Week High56.34
Enterprise Value To Ebitda22.98
Fifty Day Average51.45
Two Hundred Day Average46.80
Enterprise Value To Revenue6.72
Please also check Risk vs Return Analysis. Please also try My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. macroaxis watchlist is based on self-learning algorithm to remember stocks you like.